MILNER THERAPEUTICS SYMPOSIUM 2022
Tuesday 28th June
Cambridge, UK and Online
Milner Therapeutics Symposium 2022
Our Annual Symposium is an opportunity for scientists from academia and industry to discuss the latest academic and pre-clinical research and how it could be applied in the pharma and biotech industry to develop new treatments.
It is our key networking event for Milner Therapeutics Institute partner organisations.
If you attended the 2022 Symposium in person or online, we’re glad you could join us! Thank you to our speakers, affiliated companies and to our Platinum Sponsor Lifebit and our Bronze Sponsors AltemisLab, Eagle Genomics and Sengenics.
If you have any questions about the Symposium, please email email@example.com.
DOWNLOAD THE PROGRAMME
PHOTOGRAPHS FROM THE DAY
Information for Attendees
The Milner Therapeutics Symposium 2022 was our first hybrid symposium.
The in-person event was held at West Road Concert Hall in Cambridge, and sessions were also live-streamed to an online platform.
Oncology · CNS therapeutics · Infectious Disease · Emerging technologies · Disease-relevant models in target discovery
Simon Boulton (Artios Pharma and The Francis Crick Institute), Lori Passmore (MRC Laboratory of Molecular Biology), Ravindra Gupta (Cambridge Institute of Therapeutic Immunology and Infectious Disease), Kristian Helin (Institute of Cancer Research), Giulia Biffi (CRUK Cambridge Institute, University of Cambridge), Matthias Zilbauer (Department of Paediatrics, University of Cambridge), Richard Hargreaves (Bristol Myers Squibb) and Andras Lakatos (Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge)
You can find out more about our speakers further down this page.
Shaping the future of interdisciplinary interactions
Chaired by Kristin-Anne Rutter (Cambridge University Health Partners)
Michael Anstey (Cambridge Innovation Capital) – Jamie Blundell (Institute for the Early Detection of Cancer, University of Cambridge) – Victoria Higgins (GlaxoSmithKline) – Andy Neely (University of Cambridge) – Jeroen Verheyen (Semarion)
Posters from both academia and industry were presented in person and/or digitally as part of our hybrid Symposium. Selected posters are available for viewing on the online Symposium platform.